KHC
52
-2
RL
60
-2
VMC
42
-2
HES
49
-7
BA
33
-2
COF
49
-6
RSG
59
-6
HCA
66
4
CINF
43
-2
FSLR
52
-6
CNX
50
-3
WU
24
2
APD
27
-3
MUR
39
-4
VIX
71
6
CMS
65
-2
WAT
47
-2
URBN
24
-4
MET
44
-6
NI
60
-2
KHC
52
-2
RL
60
-2
VMC
42
-2
HES
49
-7
BA
33
-2
COF
49
-6
RSG
59
-6
HCA
66
4
CINF
43
-2
FSLR
52
-6
CNX
50
-3
WU
24
2
APD
27
-3
MUR
39
-4
VIX
71
6
CMS
65
-2
WAT
47
-2
URBN
24
-4
MET
44
-6
NI
60
-2
Financhill
Back

Stoke Therapeutics Quote, Financials, Valuation and Earnings

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Sell
45

STOK
Stoke Therapeutics

Last Price:
15.38
Seasonality Move:
-14.87%

7 Day Trial

ALL ACCESS PASS

$ 7

1-day winners in this choppy market

Get the 1-day winners strategy here.

Stoke Therapeutics Price Quote

$15.38
+0.70 (+4.77%)
(Updated: September 9, 2024 at 6:55 PM ET)

Stoke Therapeutics Key Stats

Sell
45
Stoke Therapeutics (STOK) is a Sell
Day range:
$14.16 - $15.31
52-week range:
$3.35 - $17.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
46.31
P/B ratio:
3.18%
Volume:
226K
Avg. volume:
412.3K
1-year change:
176.98%
Market cap:
$772.9M
Revenue:
$8.8M
EPS:
$-2.18

How Much Does Stoke Therapeutics Make?

Is Stoke Therapeutics Growing As A Company?

Data Unavailable

Stoke Therapeutics Stock Price Performance

What Is Stoke Therapeutics 52-Week High & Low?

Stoke Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Stoke Therapeutics?

Is Stoke Therapeutics Cash Flow Positive?

  • What Is STOK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$80M
  • What Is Stoke Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $130.3M
  • What Is Stoke Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$48.9M

Stoke Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    STOK return on invested capital is -57.17%
  • What Is Stoke Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -41.83%
  • What Is STOK Return On Equity?
    ROE is a measure of profitability and is -57.17%

Stoke Therapeutics Earnings Date & Stock Price

Stoke Therapeutics Competitors

Stoke Therapeutics Dividend Yield

Stoke Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.58%
Revenue: 0% 41.57%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.14
Upside from Last Price: 50.84%

Major Shareholders

  • How many STOK shares are owned by institutional investors?
    83.3M STOK shares are owned by institutional investors
  • How many STOK shares are owned by insiders?
    510.6K STOK shares are owned by insiders